Search Results

Mechanisms of EVAR Failure and New Surveillance Strategies

The rationale behind updating our surveillance protocols post-EVAR to decrease patient risks, as well as costs.

By Jill K. Johnstone, MD, and Gustavo S. Oderich, MD

Mechanisms of EVAR Failure and New Surveillance Strategies

The rationale behind updating our surveillance protocols post-EVAR to decrease patient risks, as well as costs.

By Jill K. Johnstone, MD, and Gustavo S. Oderich, MD

EVAR 2014

By Hence Verhagen, MD, PhD

The COBRA Trial

How will cryotherapy compare to conventional balloon angioplasty in peripheral vascular interventions?

By Sivavasavi Dinakaran, MD; Praveen Mehta, MD; Daniel Tran, MSC; Emmanouil S. Brilakis, MD; Subhash Banerjee, MD; and Tony S. Das, MD

State of EVAR in the US

By Larisse K. Lee, MD, and Peter L. Faries, MD, FACS

Safety and Feasibility of Office-Based Endovascular Procedures

Lessons learned during a 6-year experience performing dialysis access and vascular interventions in an office setting.

By Krishna M. Jain, MD; John Munn, MD; Mark Rummel, MD; Dan Johnston, MD; Syed Alam, MD; and Chris Longton, RN

Bariatric Embolization: Are Patients Actually Losing Weight?

An overview of what we currently know about weight loss expectations associated with bariatric embolization.

By Bin-Yan Zhong, MD; Godwin Abiola, BA; and Clifford R. Weiss, MD

MSK Embolization: From the Established to the Emerging

Emerging evidence supporting integration of embolization into contemporary care for musculoskeletal conditions.

By Yuji Okuno, MD, PhD

An Update on Peripheral Brachytherapy

Vascular brachytherapy still plays a role in the current treatment of restenosis.

By Ron Waksman, MD, FACC

Targeted Renal Therapy

A novel device holds promise in preventing and treating renal insufficiency.

By David E. Allie, MD; Barry S. Weinstock, MD; and Paul Teirstein, MD

Using Coiled Stents to Treat Arterial Occlusive Disease

Nitinol stent platforms, such as aSpire and Intracoil, may emerge as the most patient- and physician-friendly long-term solution for this troubling disorder.

By Gary M. Ansel, MD

Bead Technology: What’s New, What’s Next?

A review of mechanical properties and a discussion of available embolic particulates, recent advances for benign disease, novel concepts in the tumor microenvironment, and evolving use in liver cancer.

By Srinivasan Narayanan, MD, PhD; Andrea C. Cortes; and Rony Avritscher, MD

The Importance of Data-Driven Decisions in Superficial Venous Pathology to Achieve Optimal Outcomes

The role of data-driven decision making in the context of superficial venous interventions and how it can positively affect patient care.

By Sarah Onida, BSc, MBBS, MRCS, and Alun Huw Davies, MA, DM, DSc, FRCS, FHEA, FEBVS, FACPh, FFST(Ed)

The Dark Side of Embolic Protection Devices

These devices will play an important role in CAS, but their use involves some trepidation.

By Takao Ohki, MD, PhD

Suprarenal Fixation Is Safe, Effective, and Necessary

By Roy K. Greenberg, MD

Radiation Safety Considerations for the Female Interventionist

Data show that practicing while pregnant is safe, and common sense techniques will help keep it that way.

By Christine Ghatan, MD, and Nishita Kothary, MD, FSIR

Catch the WAVE

A new trial cautions against combined antiplatelet therapy and anticoagulation in treating PAD.

By Ravi K. Veeraswamy, MD, and Ross Milner, MD

PFO and Stroke: The Hidden Connection

If the results of clinical trials support the more widespread use of PFO closure, the national demand for this procedure will be potentially explosive.

By Paul Kramer, MD

Carotid Stents and Embolic Protection Devices

Mechanisms of failure and current requirements for preclinical analyses.

By Alan R. Pelton, PhD, and Roy K. Greenberg, MD